Benicar (olmesartan), a new angiotensin receptor blocker for hypertension

      Reps will soon be promoting Benicar (olmesartan), a new angiotensin receptor blocker for hypertension.

      It will be the seventh one on the market...after Cozaar (losartan), Diovan (valsartan), Avapro (irbesartan), Atacand (candesartan), Micardis (telmisartan), and Teveten (eprosartan).

      Benicar has a long half-life...but don't get too excited. It's pretty much a "me-too."

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote